This cohort study assesses the longer-term safety profile of bimekizumab in patients with moderate to severe plaque psoriasis from pooled results of 2 randomized clinical trials.
All Keywords
Communicable Diseases Research
감염병 연구데이터
This cohort study assesses the longer-term safety profile of bimekizumab in patients with moderate to severe plaque psoriasis from pooled results of 2 randomized clinical trials.